Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Early events in Epstein-Barr virus genome expression after activation: regulation by second messengers of B cell activation.

Mellinghoff I, Daibata M, Humphreys RE, Mulder C, Takada K, Sairenji T.

Virology. 1991 Dec;185(2):922-8.

PMID:
1660209
2.

Activation of latent EBV via anti-IgG-triggered, second messenger pathways in the Burkitt's lymphoma cell line Akata.

Daibata M, Humphreys RE, Takada K, Sairenji T.

J Immunol. 1990 Jun 15;144(12):4788-93.

PMID:
2161880
3.

Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells.

Daibata M, Speck SH, Mulder C, Sairenji T.

Virology. 1994 Feb;198(2):446-54.

PMID:
8291228
4.

Effect of genistein, a tyrosine kinase inhibitor, on latent EBV activation induced by cross-linkage of membrane IgG in Akata B cells.

Daibata M, Mellinghoff I, Takagi S, Humphreys RE, Sairenji T.

J Immunol. 1991 Jul 1;147(1):292-7.

PMID:
1711079
5.
6.

Cyclosporin A and FK506 block induction of the Epstein-Barr virus lytic cycle by anti-immunoglobulin.

Goldfeld AE, Liu P, Liu S, Flemington EK, Strominger JL, Speck SH.

Virology. 1995 May 10;209(1):225-9.

7.

Dissociation of EBV genome replication and host cell proliferation in anti-IgG-stimulated Akata cells.

Takase K, Kelleher CA, Terada N, Jones JF, Lucas JJ, Gelfand EW.

Clin Immunol Immunopathol. 1996 Nov;81(2):168-74.

PMID:
8906748
9.

Virus and cell RNAs expressed during Epstein-Barr virus replication.

Yuan J, Cahir-McFarland E, Zhao B, Kieff E.

J Virol. 2006 Mar;80(5):2548-65.

12.

Pathways of activation of the Epstein-Barr virus productive cycle.

Sinclair AJ, Brimmell M, Shanahan F, Farrell PJ.

J Virol. 1991 May;65(5):2237-44.

13.

The BRRF1 early gene of Epstein-Barr virus encodes a transcription factor that enhances induction of lytic infection by BRLF1.

Hong GK, Delecluse HJ, Gruffat H, Morrison TE, Feng WH, Sergeant A, Kenney SC.

J Virol. 2004 May;78(10):4983-92.

14.

[The mechanisms of Epstein-Barr virus activation in B cells].

Sairenji T.

Nihon Rinsho. 1997 Feb;55(2):316-20. Review. Japanese.

PMID:
9046817
15.

Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.

Cordier M, Calender A, Billaud M, Zimber U, Rousselet G, Pavlish O, Banchereau J, Tursz T, Bornkamm G, Lenoir GM.

J Virol. 1990 Mar;64(3):1002-13.

16.
17.

Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.

Quinlivan EB, Holley-Guthrie EA, Norris M, Gutsch D, Bachenheimer SL, Kenney SC.

Nucleic Acids Res. 1993 Jul 11;21(14):1999-2007.

18.

Early events in Epstein-Barr virus infection of human B lymphocytes.

Alfieri C, Birkenbach M, Kieff E.

Virology. 1991 Apr;181(2):595-608. Erratum in: Virology 1991 Dec;185(2):946.

PMID:
1849678
19.

Methylation-dependent binding of the epstein-barr virus BZLF1 protein to viral promoters.

Dickerson SJ, Xing Y, Robinson AR, Seaman WT, Gruffat H, Kenney SC.

PLoS Pathog. 2009 Mar;5(3):e1000356. doi: 10.1371/journal.ppat.1000356. Epub 2009 Mar 27.

Supplemental Content

Support Center